Diabetes Topics

The On-Topic Netowork

Diabetes > Endogenous


Endogenous
Endogenous
Endogenous
Endogenous
Endogenous

The following information is about Endogenous.

Endogenous Defined

Produced or made inside the body; for instance, insulin made by a person's own pancreas is endogenous insulin.Pronounced: en-DODGE-in-usCompare: Exogenous

This definition is in context to Diabetes. See more contextual defintions for Endogenous.


Navigation: [ 1 2 3 Next ]

Cystic Fibrosis Axentis Pharma Initiates Clinical Trial For Lung Infections

Published September 5, 2008, 7:14 am, Medical News Today

Axentis Pharma AG has initiated a clinical phase IIa trial to assess the safety and tolerability of a new therapeutic formulation for the treatment of severe pulmonary infection in cystic fibrosis patients. The new formulation allows an established therapeutic agent to be delivered directly to the site of infection.

Full Story


Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections

Published September 4, 2008, 6:00 am, PR Newswire via Yahoo! Finance

Axentis Pharma AG has initiated a clinical phase IIa trial to assess the safety and tolerability of a new therapeutic formulation for the treatment of severe pulmonary infection in cystic fibrosis patients.

Full Story


Triumphs And Tragedies In Advances In The Management Of Patients With Diabetes Mellitus:

Published September 3, 2008, 5:09 am, Medical News Today

The need for long term studies to establish the best means of treating Diabetes, was underlined by Prof John Cleland from the University of Hull at the ESC Congress in Munich. Prof Cleland listed the latest treatment available for patients and voiced his concern about the side-effects and efficacy of available anti-diabetic drugs.

Full Story


First inhibitor of dihydroceramide desaturase. Method to decrease intracellular levels of ceramide.

Published September 2, 2008, 11:09 am, Pharmalicencing

SUMMARY This technology is related to synthesis of a cyclopropenyl analog of ceramide as a potent inhibitor of dihydroceramide desaturase, which is the last enzyme in the biosynthesis "de novo" of ceramide.

Full Story


ApoA-I Data Presented at European Society of Cardiology Congress

Published September 2, 2008, 10:28 am, FinanzNachrichten

Calgary, Canada (ots/PRNewswire) - - Multiple Presentations Included Resverlogix Data - TSX Exchange Symbol: RVX Resverlogix Corp. ("Resverlogix" ...

Full Story


ApoA-I Data Presented at European Society of Cardiology Congress

Published September 2, 2008, 10:12 am, Presseportal

Calgary, Canada (ots/PRNewswire) - - Multiple Presentations Included Resverlogix Data - TSX Exchange Symbol: RVX Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) is pleased to announce that Dr. Norman Wong ...

Full Story


ApoA-I Data Presented at European Society of Cardiology Congress

Published September 2, 2008, 9:58 am, PR Newswire via Yahoo! Finance

Resverlogix Corp. is pleased

Full Story


ApoA-I Data Presented at European Society of Cardiology Congress

Published September 2, 2008, 9:27 am, CNW Group via Yahoo! Finance

Resverlogix Corp. is pleased to announce that Dr. Norman Wong presented key clinical data pertaining to its lead compound, RVX-208, at the European Society Cardiology 2008 Congress in Munich.

Full Story


Alcoholism-associated molecular adaptations

Published September 2, 2008, 8:19 am, EurekAlert!

( European College of Neuropsychopharmacology ) At the 21st Congress of the ECNP 2008 in Barcelona, Prof. Georgy Bakalkin, involved in research focusing on biochemical mechanisms underlying neuropsychiatric disorders, highlighted the latest findings on this clinical challenge and presented a novel mechanism and understanding of cognitive deficit in human alcoholics. Thereby an emerging concept ...

Full Story


Broad Institute awarded grant to develop chemical probes for human biology and disease

Published September 2, 2008, 7:47 am, EurekAlert!

( Broad Institute of MIT and Harvard ) Researchers at the Broad Institute of Harvard and MIT have been chosen to receive a six-year, approx. $86M grant from the National Institutes of Health to identify and develop molecular tools known as "small molecules," which can probe the proteins, signaling pathways and cellular processes that are crucial to human health and disease.

Full Story


Navigation: [ 1 2 3 Next ]

Are you looking for additional Diabetes > Endogenous news? Try our new "Endogenous News Focus" area.

Off-site Endogenous Links, User Submitted

The following links have been collected through user bookmark submission in the Endogenous category. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.

Wed Aug 20

Fri Jul 11

Wed Jul 2

Sun Jun 29

Fri Jun 6

Sat May 31

Thu May 1

Fri Apr 25

  • MMOG of My Dreams: "...the enrichment of life itself through its fusion with fiction, a true Dreaming, an almost-sacred possibility of communion with imagination... conflict without tragedy, narrative motion without the boredom of everyday life, defeat without suffering...

Tue Apr 8

Tue Mar 18

  • General Equilibrium with Endogenous Uncertainty and Default: We study the introduction of new assets that are defined in expected values rather than state by state. Individual default emerges naturally in an economy where such assets are introduced without completing all contingency markets. We further provide cond

If you would like to find additional social bookmark based links on the topic of we recommend the Open Tag Directory > Endogenous. If you would like to find related tags we recommend Tag Patterns > Endogenous

Off-site Endogenous Research Links

If you still need additional information on Endogenous then we suggest the following off-site resources. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.

Diabetes

If you know the Diabetes Term Name use the links below to quickly jump to your desired focus.



Bookmark Us

The On Topic Network

This website is part of The On Topic Network.

Thank You

Diabetes.On-Topic.net was developed by Odin Metatech, Inc and runs on the Odin Assemble platform.

Best Viewed With

License

Creative Commons License This work is licensed under Creative Commons.




Powered by Odin Assemble 2.5a